LANGAR INVESTMENT MANAGEMENT ANNOUNCES TRANSFER OF THE LANGAR GLOBAL HEALTHTECH ETF TO THE CBOE BZX EXCHANGE

Rhea-AI Summary

Langar Investment Management, adviser to the Langar Global HealthTech ETF (LGHT), will transfer the ETF's primary listing from NYSE Arca to the Cboe BZX Exchange on or about June 29, 2026.

Shareholders need not take action; the Fund's objective, strategy, and management team remain unchanged.

News Market Reaction – LGHT

-3.34%

-3.34% Session close to close

In the Jul 8 session, LGHT declined 3.34%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The planned transfer of LGHT’s primary listing to Cboe BZX on June 29, 2026 leaves its objective and...

Analysis

The planned transfer of LGHT’s primary listing to Cboe BZX on June 29, 2026 leaves its objective and management intact, framing this as an operational change. Investors may monitor how spreads and premiums or discounts to NAV behave after the move.

Key Figures

Listing transfer date: June 29, 2026

1 metrics

Listing transfer date June 29, 2026 Target date to move primary listing of LGHT to Cboe BZX

Key Terms

net asset value, prospectus

2 terms

net asset value financial

"The Fund's shares are bought and sold at market price, not at net asset value"

Net asset value is the total value of an investment fund's assets minus any liabilities, divided by the number of shares or units outstanding. It represents the per-share worth of the fund, similar to how the value of a house is determined by its total worth after debts are subtracted. Investors use it to gauge the true value of their holdings and to compare different investment options.

View in glossary

prospectus regulatory

"This material must be preceded or accompanied by a current prospectus."

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LOS ANGELES, July 7, 2026 /PRNewswire/ -- Langar Investment Management LLC, the adviser to the Langar Global HealthTech ETF (NYSE Arca: LGHT), today announced the transfer of the primary listing of LGHT from NYSE Arca to the Cboe BZX Exchange on or about June 29, 2026.

Current shareholders of LGHT are not required to take any action, nor is the transfer expected to have any effect on the trading of the Fund's shares. The Fund's investment objective, strategies, and investment management team will remain unchanged.

For more information on the Langar Global HealthTech ETF, please visit langarfunds.com.

About Langar Investment Management

Langar Investment Management is the investment management subsidiary of Langar Technology, Inc. and the adviser to the Langar Global HealthTech ETF (LGHT) — the first ever pure-play healthtech ETF. LGHT seeks long-term growth of capital and offers investors targeted exposure to companies at the intersection of healthcare and technology, including digital health, medical devices, health data infrastructure, and AI-driven diagnostics. For more information, visit langarfunds.com.

Important Disclosures

Nothing contained in this material should be construed as an offer to sell nor a solicitation of an offer to buy shares of the Langar Global HealthTech ETF. This material must be preceded or accompanied by a current prospectus. Investors should read the prospectus carefully before investing.

Investing involves risk, including possible loss of principal. The Fund's shares are bought and sold at market price, not at net asset value ("NAV") per share. The shares may trade at a premium or discount to NAV. Brokerage commissions will reduce returns.

The Langar Global HealthTech ETF is distributed by Paralel Distributors LLC. Paralel Distributors LLC is not affiliated with Langar Investment Management or Langar Technology, Inc.

LAN10.

View original content:https://www.prnewswire.com/news-releases/langar-investment-management-announces-transfer-of-the-langar-global-healthtech-etf-to-the-cboe-bzx-exchange-302819919.html

SOURCE Langar Technology, Inc.

FAQ

What change did Langar Global HealthTech ETF (LGHT) announce on July 7, 2026?

Langar Global HealthTech ETF (LGHT) announced its primary listing will move from NYSE Arca to the Cboe BZX Exchange on or about June 29, 2026. According to Langar, the fund’s objective, strategy, and management team will stay the same.

When will LGHT transfer its primary listing from NYSE Arca to Cboe BZX Exchange?

Langar Global HealthTech ETF (LGHT) expects to transfer its primary listing to the Cboe BZX Exchange on or about June 29, 2026. According to Langar, this is a listing venue change and does not alter the fund’s investment objective or strategies.

Do Langar Global HealthTech ETF (LGHT) shareholders need to do anything for the Cboe BZX listing transfer?

Current LGHT shareholders are not required to take any action for the transfer to the Cboe BZX Exchange. According to Langar, the move is not expected to affect how the fund’s shares trade in the market.

Will the investment objective or strategy of LGHT change after moving to the Cboe BZX Exchange?

The investment objective and strategies of LGHT will remain unchanged after the listing transfer to Cboe BZX. According to Langar, the same investment management team will continue to run the ETF with its existing healthtech focus.

What does the Langar Global HealthTech ETF (LGHT) invest in?

LGHT seeks long-term capital growth by targeting companies at the intersection of healthcare and technology. According to Langar, the ETF focuses on areas like digital health, medical devices, health data infrastructure, and AI-driven diagnostics, offering pure-play healthtech exposure.

What are key risks of investing in the Langar Global HealthTech ETF (LGHT)?

Investing in LGHT involves risk, including possible loss of principal. According to Langar, shares trade at market price and may trade at a premium or discount to NAV, and brokerage commissions can reduce investor returns.